[Federal Register Volume 72, Number 234 (Thursday, December 6, 2007)]
[Notices]
[Page 68887]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: E7-23633]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention

[30Day-08-0307]


Agency Forms Undergoing Paperwork Reduction Act Review

    The Centers for Disease Control and Prevention (CDC) publishes a 
list of information collection requests under review by the Office of 
Management and Budget (OMB) in compliance with the Paperwork Reduction 
Act (44 U.S.C. Chapter 35). To request a copy of these requests, call 
the CDC Reports Clearance Officer at (404) 639-5960 or send an e-mail 
to [email protected]. Send written comments to CDC Desk Officer, Office of 
Management and Budget, Washington, DC or by fax to (202) 395-6974. 
Written comments should be received within 30 days of this notice.

Proposed Project

    Gonococcal Isolate Surveillance Project (GISP)--Revision--National 
Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention (NCHHSTP), 
Centers for Disease Control and Prevention (CDC).

Background and Brief Description

    CDC is requesting a 3-year revision with change for this project. 
The objectives of GISP are to monitor trends in antimicrobial 
susceptibility of strains of Neisseria gonorrhoeae in the U.S. and 
characterize resistant isolates. GISP provides critical surveillance 
for antimicrobial resistance, allowing for informed treatment 
recommendations.
    This project began in 1986 as a voluntary surveillance project and 
has involved 5 regional laboratories and 30 publicly-funded, sexually 
transmitted disease (STD) clinics around the country. The STD clinics 
submit up to 25 gonococcal isolates per month to the regional 
laboratories, which measure susceptibility to a panel of antibiotics. 
Limited demographic and clinical information corresponding to the 
isolates are submitted directly by the STD clinics to CDC.
    During 1986-2006, GISP has demonstrated the ability to effectively 
achieve its objectives. The emergence of resistance in the United 
States to penicillin, tetracyclines, and now fluoroquinolones was 
identified through GISP and makes ongoing surveillance critical. 
Increased prevalence of fluoroquinolone-resistant N. gonorrhoeae (QRNG) 
as seen in GISP data has prompted the CDC to update the treatment 
recommendations for gonorrhea in the CDC's Sexually Transmitted 
Diseases Treatment Guidelines, 2006 and to release an MMWR article 
stating the CDC no longer recommends fluoroquinolones for treatment of 
gonococcal infections (CDC, MMWR, Vol.56, No.14, 332-336). Respondents 
are paid by Federal funds through the CDC Comprehensive STD Prevention 
Systems, Prevention of STD-Related Infertility, and Syphilis 
Elimination Grant (CSPS), for their participation in GISP network. The 
estimated annualized burden for this data collection is 8,628 hours.

                                        Estimated Annualized Burden Hours
----------------------------------------------------------------------------------------------------------------
                                                                                     No. of        Avg. burden
         Type of respondent                  Form name              No. of       responses per     per response
                                                                 respondents       respondent       (in hours)
----------------------------------------------------------------------------------------------------------------
Clinic..............................  Form 1.................               30              240            11/60
Laboratory..........................  Form 2.................                5            1,452                1
                                      Form 3.................                5               48            12/60
                                     ---------------------------------------------------------------------------
    Total...........................  .......................               40  ...............  ...............
----------------------------------------------------------------------------------------------------------------


    Dated: November 28, 2007.
Maryam I. Daneshvar,
Acting Reports Clearance Officer.
[FR Doc. E7-23633 Filed 12-5-07; 8:45 am]
BILLING CODE 4163-18-P